I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates, 12/2/24:  Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Embecta discontinues insulin patch pump development by Elise Reuter for MedTechDive.com, 26 November 2024. Embecta said it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The...

read more
Savvy Updates, 11/25/24:  FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

In this week's issue of The Savvy Diabetic:  FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU CAN MAKE A...

read more
Savvy Updates 11/18/24:  NovoNordisk Phasing Out Human Insulin Pens, Sequel/Twiist AID, History of Artificial Pancreas

Savvy Updates 11/18/24: NovoNordisk Phasing Out Human Insulin Pens, Sequel/Twiist AID, History of Artificial Pancreas

Novo Nordisk says it is gradually phasing out human insulin pens globally by Maggie Fick for Reuters.com, 14 November 2024. Novo Nordisk is gradually ending production of human insulin pens, as it spends billions to ramp up manufacturing of its popular obesity and...

read more
Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the...

read more
Savvy Updates, 11/4/24:  O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

In this week's issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott FreeStyle...

read more
Savvy Updates: 10/28/24:  Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

In this week's issue of The Savvy Diabetic:  New Insulin to Prevent Sudden BG Drops Luna Diabetes Clinical Trial for AID Closed-Loop for MDI Levicure's Triple-Combo Oral Therapy to Restore Insulin Production GLP-1, SGLT2 Drug Scripts on the Rise for T1Ds...

read more
Savvy Updates, 10/21/24:  Stem Cell Research News, GLP-1s with AIDs, FDA Removes GLP-1s from Shortage List, Tzield Delays T1D Onset in Teen

Savvy Updates, 10/21/24: Stem Cell Research News, GLP-1s with AIDs, FDA Removes GLP-1s from Shortage List, Tzield Delays T1D Onset in Teen

In this week's issue of The Savvy Diabetic:  A Cure for T1D by Disguising Stem Cells? Stem Cell-Derived Islets Restore Insulin Production in T1D GLP1-RAs and T1D with Open Source AIDs FDA Removes Zepbound & Mounjaro from Shortage List Teen Receives Teplizumab...

read more
Savvy Updates 10/14/24:  GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

In this week's issue of The Savvy Diabetic:  GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs Work...

read more
Share This
Skip to content